These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26552968)

  • 21. In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model.
    Andes D; Diekema DJ; Pfaller MA; Prince RA; Marchillo K; Ashbeck J; Hou J
    Antimicrob Agents Chemother; 2008 Feb; 52(2):539-50. PubMed ID: 18070979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
    Mehta PA; Vinks AA; Filipovich A; Bleesing J; Jodele S; Jordan MB; Marsh R; Tarin R; Edwards S; Fearing D; Lawrence J; Davies SM
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1458-62. PubMed ID: 20546908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
    Jullien V; Azoulay E; Schwebel C; Le Saux T; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Cour M; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Wolff M; Timsit JF;
    J Antimicrob Chemother; 2017 Jan; 72(1):181-189. PubMed ID: 27609051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E; Grau S; Villagran MJ; Hernandez-Gancedo C; Lopez-Tofiño A; Roberts JA; Aguilar L; Luque S; Sevillano D; Gimenez MJ; Gilsanz F
    J Antimicrob Chemother; 2014 Jun; 69(6):1624-32. PubMed ID: 24505092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of fungicidal activity against Candida tropicalis on the efficacy of micafungin and liposomal amphotericin B in a neutropenic murine lethal infection model.
    Takemoto K; Nakayama T; Kanazawa K; Ueda Y
    Pharmacology; 2012; 90(3-4):133-45. PubMed ID: 22847175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Echinocandins in antifungal pharmacotherapy.
    Patil A; Majumdar S
    J Pharm Pharmacol; 2017 Dec; 69(12):1635-1660. PubMed ID: 28744860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and Safety of Micafungin in Infants Supported With Extracorporeal Membrane Oxygenation.
    Autmizguine J; Hornik CP; Benjamin DK; Brouwer KL; Hupp SR; Cohen-Wolkowiez M; Watt KM
    Pediatr Infect Dis J; 2016 Nov; 35(11):1204-1210. PubMed ID: 27314826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
    Grau S; Luque S; Campillo N; Samsó E; Rodríguez U; García-Bernedo CA; Salas E; Sharma R; Hope WW; Roberts JA
    J Antimicrob Chemother; 2015 Oct; 70(10):2854-61. PubMed ID: 26180134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echinocandin pharmacodynamics: review and clinical implications.
    Pound MW; Townsend ML; Drew RH
    J Antimicrob Chemother; 2010 Jun; 65(6):1108-18. PubMed ID: 20335190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Echinocandin Resistance in Candida.
    Perlin DS
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.
    Hope WW; Mickiene D; Petraitis V; Petraitiene R; Kelaher AM; Hughes JE; Cotton MP; Bacher J; Keirns JJ; Buell D; Heresi G; Benjamin DK; Groll AH; Drusano GL; Walsh TJ
    J Infect Dis; 2008 Jan; 197(1):163-71. PubMed ID: 18171300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis.
    Mochizuki K; Suemori S; Udo K; Komori S; Ohkusu K; Yamada N; Ogura S
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):531-3. PubMed ID: 21751880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans.
    Venisse N; Grégoire N; Marliat M; Couet W
    Antimicrob Agents Chemother; 2008 Mar; 52(3):937-43. PubMed ID: 18180347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections.
    Liu P
    Antimicrob Agents Chemother; 2013 Jan; 57(1):466-74. PubMed ID: 23129052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.